论文信息 - The GOFURTGO Study: AGITG Phase II Study of fixed dose rate gemcitabine–oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer - 字舞流文

The GOFURTGO Study: AGITG Phase II Study of fixed dose rate gemcitabine–oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer

V. Gebski | D. Goldstein | S. Ackland | N. Spry | G. van Hazel | J. Shapiro | S. Bydder | C. Wratten | G. Hruby | M. Borg | M. Cummins | C. Brown | J. Harvey | L. Horvath | C. Underhill | I. Porter | S. Carroll | S. Selva‐Nayagam | G. V. van Hazel | S. Selva-nayagam